Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

Pharmacyclics' MRI contrast agent deemed approvable

Dec. 20, 1996

Licensees sought for MAbs specific for P-450 enzymes

Dec. 20, 1996

Licenses offered for marker in the human iNOS gene promoter region

Dec. 19, 1996

Radiopharmaceutical agents from CIS Bio International

Dec. 19, 1996

Molecular Biosystems and Mallinckrodt expand contrast agent agreement

Dec. 18, 1996

Beacon obtains rights to Centocor tumor markers

Dec. 18, 1996

New imaging agents for 19F MRI claimed by Molecular Biosystems

Dec. 17, 1996

CRC and Cortecs to develop cancer diagnostic tests

Dec. 16, 1996

Oncogene Science and Bayer initiate cancer diagnostics collaboration

Dec. 16, 1996

Oncor expands marketing of breast cancer test

Dec. 16, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.